Search

Four-year doctoral position in the Microbial Evolutionary Genetics (MEG) Lab led by Johannes Cairns, Department of Experimental Medical Science, Lund University. The project investigates how species interactions shape antibiotic responses,

The University of Santo Tomas BEATS delegation presented four studies—one oral presentation and three posters—at Phages 2026 in Oxford on September 1–2. The work covered bacteriophages, microbial ecology and antimicrobial resistance. Univer

A CNN report on antimicrobial resistance follows the family of an Indonesian infant whose parents believe resistance played a role in his death, and Mallory Smith, a cystic fibrosis patient who died at 25 from a B. cepacia infection that an

In an episode of Stanford Medicine's The Future of Medicine, hematologist and microbiome researcher Dr. Ami Bhatt discusses tracing about 40% of bloodstream infections in a Stanford bone marrow transplant population to microbes already livi

A peer-reviewed expanded-access case report in Clinical Infectious Diseases describes investigational SNIPR001 use in a kidney transplant recipient with progressive multidrug-resistant Escherichia coli malakoplakia, under a single-patient e

Argentina, Paraguay, Uruguay and Brazil’s São Paulo and Espírito Santo agencies jointly supported research and knowledge transfer on antimicrobial resistance in intensive food-animal production. Projects could run up to 24 months, with agen

Contagion Live article by Amer El-Ghali and Dana Holger reviewing phage-antibiotic combinations (PACs) in refractory multidrug-resistant infections: preclinical synergy is consistent and compassionate-use reports show safety and frequent cl

PHTRP lists a patient-perspective panel discussion on experiences with phage therapy. Phage Hunters Training and Research Program

PHTRP lists its fifth AMR and phage therapy panel discussion, “Building a Career in Phage Research.” Phage Hunters Training and Research Program

Silver nanoparticles templated by the Escherichia coli phage M13 showed unusually high potency against Gram-negative pathogens including E. coli, Pseudomonas aeruginosa and Vibrio cholerae in vitro, and elicited resistance more than 10-fold

The Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, is hosting the 6th International Conference on Bacteriophage Research and Antimicrobial Resistance (ICBRAR-2025) under the Society for Bacteriophage Re

Entelli-02 is a five-phage cocktail built from The Alfred Hospital's decade-long isolate collection against multidrug-resistant Enterobacter cloacae complex; it covers 88% of the hospital's 206 isolates and reduced bacterial load in septica

Harvard Undergraduate Microbiology Society explainer by Srikara Tadigotla on phage-antibiotic synergy (PAS), which pairs inexpensive antibiotics with adaptable phages so that bacteria must trade off phage resistance against antibiotic resis

The American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA) are hosting the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation, taking place on January 28-30, 2026. The conference aims

Report from the WHO Regional Office for Europe and the Global Antimicrobial Resistance Research and Development Hub, published 26 May 2025, on advancing the evidence for using bacteriophages against antimicrobial resistance under a One Heal

In vitro, curcumin (400 ug/mL) combined with the newly isolated phage vB_AbaSI_1 reduced multidrug-resistant A. baumannii to undetectable levels within 1 hour, and a double dose extended this to 5 hours, whereas phage alone rebounded within

WHO/Europe fact sheet explaining that therapeutic phages are lytic and highly specific to their bacterial hosts and can be used alone or alongside antibiotics, but are not approved medicines in most countries and are mainly used on compassi

Stephen Theriault, CEO of Cytophage, gave a TED Talk on Harnessing Phages to Combat Superbugs, exploring how phages can address antibiotic resistance. A scientist, entrepreneur, and former member of Canada’s Ebola vaccine team, he shares hi

How long until governments can subscribe to antimicrobials (instead of paying per use), so it will finally be economically viable to develop them? Italy is now the second country (after the UK) to create a path for this! Damiano de Felice a

NIAID has two grants open that fit could fit your phage research! 1) the 2026 Omnibus Broad Agency Announcement supports work on infectious diseases, including AMR and countermeasures; 2) the CARBIRUs (Combating Antibiotic-Resistant Bacte